Fast Company announces Steph Sherer, President of the International Cannabis and Cannabinoids Institute (ICCI) and founder of Americans for Safe Access (ASA), as one of the 2019 100 Most Creative People.
“For the last 17 years, I have worked to break-down societal and governmental barriers for patients who need access to medical cannabis. Now that these barriers are tumbling down it is important that industry evolves to provide products for these populations that are safe, standardized and targeted and that there is the scientific infrastructure to support these efforts. I am excited to extend my advocacy for access to medical cannabis to include the scientific community, investors, and sectors of the industry that are committed to serving the patient community.” – Steph Sherer, ICCI Co-Founder, and President
ICCI was founded as a joint project of patient organizations, scientific societies and American investment company Dioscorides Global Holdings (DGH). The headquarters are located in Prague, and as a center of excellence, it cooperates internationally with governments, universities and research institutes as well as companies in the cannabis, hemp, biotech, and agricultural sectors.
Sherer co-founded DGH, a private equity firm that invests strategically in medical cannabis, with partner Ben Bronfman. Sherer is the foremost international leader and expert on medical cannabis patient advocacy. In 2002, Sherer founded Americans for Safe Access (ASA) the largest national member-based organization of patients, medical professionals, scientists, and concerned citizens promoting safe and legal access to cannabis for therapeutic use and research. For seventeen years, Sherer's leadership guided the efforts, with lawmakers across the US and globally, to adapt and improve medical cannabis legislation and regulatory policy across the US and its territories as well as representing patients on Capitol Hill. Alongside the American Herbal Products Association (AHPA) and the American Herbal Pharmacia, Sherer co-created the first medical cannabis industry standards in the areas of Distribution, Cultivation, Analytics, and Manufacturing, Packaging, and Labeling.
Through her work as Founder and Executive Director of Americans for Safe Access (ASA), Sherer has made medical cannabis available to patients worldwide. During her time as Executive Director of ASA, Sherer was responsible for the drafting of some of the first distribution laws in the United States and has been a leader in bringing patients to the table with lawmakers. Now she comes to Prague to run the International Institute for Cannabis and Cannabinoids (ICCI).
About the ICCI
The International Cannabis and Cannabinoids Institute (ICCI) was established as a joint project of patient organizations, Czech scientific societies and the investment firm Dioscorides Global Holdings.
The main headquarters are in Prague, Czech Republic. ICCI cooperates with universities (such as Charles University, the Czech Technical University or the Hebrew University in Jerusalem), hi-tech companies and associations. Furthermore, ICCI identifies, coordinates and supports global research priorities for the advancement of cannabis and cannabinoid treatments through a multidiscipline, evidence-based approach that incorporates innovative tools and methods.